Compare Immunovant Inc. Common Stock (IMVT) vs Transocean Ltd (RIG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Immunovant Inc. Common Stock vs Transocean Ltd — how do they compare? Immunovant Inc. Common Stock trades at $30.01 (market cap $6.62B), while Transocean Ltd trades at $5.54 (market cap $6.02B). The key difference: Immunovant Inc. Common Stock and Transocean Ltd are close in size by market cap, and Transocean Ltd is more actively traded (19,180,005 versus 1,131,364). Which is the better fit depends on your goals — on Pluang, investors hold Immunovant Inc. Common Stock for 0 Days and Transocean Ltd for 18 Days on average.
| IMVT | RIG | |
|---|---|---|
Market Cap | $6.62B | $6.02B |
Volume | 1,131,364 | 19,180,005 |
Sector | Health | Energy |
52-Week High | $44.96 | $7.58 |
52-Week Low | $17.03 | $3.08 |
Typical Hold Time | 0 Days | 18 Days |
Enterprise Value | $5.72B | $10.63B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
RIG trades at $5.39, down 0.19% on the day, with a mixed technical picture showing bearish moving averages but neutral oscillators. The company reported a net loss of $2.92 billion in 2025, though revenue remains solid at $3.97 billion. Recent news highlights progress on the $5.8 billion Valaris acquisition and new contract wins, while analyst sentiment is divided with a 39% buy rating.
The outlook hinges on successful deleveraging and offshore cycle strength, but high debt and persistent losses pose significant risks. Investment appeal is speculative, dependent on cash flow improvements and debt reduction outweighing current profitability challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Immunovant Inc. Common Stock
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →About Transocean Ltd
Transocean Ltd. is a leading international provider of offshore contract drilling services for oil and gas wells. The company operates one of the world's most versatile fleets of mobile offshore drilling units, including ultra-deepwater drillships and harsh environment semi-submersibles. RIG's services are essential to energy exploration and production companies seeking to access deepwater and challenging reserves globally.
Read more on RIG →
